Abstract The Cannabis plant (Cannabis sativa L.), also known as hemp, is a sustainable and
multipurpose plant that may be used for a wide range of purposes, from the fiber in its stalks …

Endocannabinoids were implicated in a variety of pathological conditions including anxiety
and are considered promising new targets for anxiolytic drug development. The optimism …

Cannabidiol (CBD), a cannabinoid that does not create psychoactive activities, has been
identified as having a multitude of therapeutic benefits. This study delves into the chemical …

Introduction: An altered neurodevelopmental trajectory associated with prenatal exposure
to∆-9-tetrahydrocannabinol (THC) leads to aberrant cognitive processing through a …

Cannabis-infused edibles are food products infused with a cannabis extract. These edibles
include baked goods, candies, and beverages, offering an alternative way to consume …

Background Cannabinoid drugs containing tetrahydrocannabinol (THC), or its structural
analogues, as monotherapeutic agents or as extracts or botanical preparations with or …

Abstract Background Δ9-Tetrahydrocannabinol (Δ9-THC) is a principal psychoactive extract
of Cannabis sativa and has been traditionally used as palliative medicine for neuropathic …

Cannabidiol (CBD) has become a highly attractive entity in therapeutics. However, its low
aqueous solubility, instability and handling problems limit the development of effective CBD …

Cannabidiol (CBD), the main non-psychoactive component of Cannabis sativa L., is widely
used in therapy for the treatment of different diseases and as an adjuvant drug. Our aim was …

Cannabis-based products have gained attention in recent years for their perceived
therapeutic benefits (with cannabinoids such as THC and CBD) and widespread availability …